| Drug Type Antibody | 
| Synonyms GB-7002 | 
| Target | 
| Action inhibitors | 
| Mechanism CD73 inhibitors(5-nucleotidase inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Inactive Organization- | 
| License Organization | 
| Drug Highest PhaseIND Application | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Stomach Cancer | IND Application | China  | - | |
| Stomach Cancer | IND Application | China  | - | |
| Solid tumor | Preclinical | China  | 30 Jan 2022 | 






